1978
DOI: 10.1287/mnsc.24.15.1611
|View full text |Cite
|
Sign up to set email alerts
|

A Simultaneous Equation Model of Corporate Strategy

Abstract: Over the past decade strategy has become a concept of value to management as it relates the firm to the threats and opportunities of an increasingly turbulent environment. However, empirical tests of the validity of the strategy construct have been limited, as have been the managerial applications of the models used to test the construct. Early research efforts, both analytical and empirical, have shown that quantitative modeling of strategy could be a tool of value in helping top management achieve the goal i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
60
0
4

Year Published

1983
1983
2005
2005

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 169 publications
(65 citation statements)
references
References 5 publications
1
60
0
4
Order By: Relevance
“…Future research should examine if strategic balance theory applies in other markets facing strong competitive and institutional pressures, such as hospitals or drug manufacturers. The specific strategic resource commitments in these markets may vary (Chandler, 1962;Schendel and Patton, 1978). For instance, R&D expenses and advertising expenses may be important in the pharmaceutical industry (Cool and Schendel, 1987), whereas technical sophistication in non-routine treatments may be important in hospitals (Ketchen, Thomas, and Snow, 1993;Westphal, Gulati, and Shortell, 1997).…”
Section: Towards a Comprehensive Theory Of Strategic Balancementioning
confidence: 99%
“…Future research should examine if strategic balance theory applies in other markets facing strong competitive and institutional pressures, such as hospitals or drug manufacturers. The specific strategic resource commitments in these markets may vary (Chandler, 1962;Schendel and Patton, 1978). For instance, R&D expenses and advertising expenses may be important in the pharmaceutical industry (Cool and Schendel, 1987), whereas technical sophistication in non-routine treatments may be important in hospitals (Ketchen, Thomas, and Snow, 1993;Westphal, Gulati, and Shortell, 1997).…”
Section: Towards a Comprehensive Theory Of Strategic Balancementioning
confidence: 99%
“…For example, in Cell 1, the operationalizing scheme for business performance entails the use of financial performance data obtained from secondary sources (e.g.. Beard & Dess, 1981;Rumelt, 1974), while in Cell 2, the focus is on eliciting financial data directly from target organizations (e.g., ROI in PIMSbased studies). In Cells 3 and 4, the focus Is on operational indicators collected from secondary sources (e.g., market share data in Schendel & Patton, 1978) and primary sources (e.g., data on market share positions in PIMS-based studies) respectively. It is readily apparent that these four approaches have a narrow perspective on the notion of business performance.…”
Section: Wthln-cell^prochesmentioning
confidence: 99%
“…First, a range of studies finds that the number of groups in an industry does not change dramatically over time. Indeed, in the industries studied in Schendel and Paton (1978), Harrigan (1985), Hatten and Schendel (1987), Cool and Schendel (1988), Mascarenhas (1989) and Fiegenbaum and Thomas (1990), the number of basic groups was stable, varying between three and five over the time periods studied. From a hypercompetition point of view, the stability evidence is limited, as the researchers did not consider the introduction of new competitive dimensions by firms in their formulation frameworks.…”
Section: Strategic Groupsmentioning
confidence: 93%